{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "BRU", "shortName": "BIOSENIC", "longName": "BioSenic S.A.", "messageBoardId": "finmb_333665998", "market": "be_market", "marketState": "REGULAR", "earningsTimestamp": 1685012340, "earningsTimestampStart": 1685012340, "earningsTimestampEnd": 1685012340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.45, "epsForward": -0.11, "epsCurrentYear": 0.04, "priceEpsCurrentYear": 2.9375, "sharesOutstanding": 124009000, "fiftyDayAverage": 0.12961, "fiftyDayAverageChange": -0.012110002, "fiftyDayAverageChangePercent": -0.09343416, "twoHundredDayAverage": 0.1609025, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Brussels", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -10.984848, "regularMarketPrice": 0.1175, "regularMarketChange": -0.0145, "regularMarketTime": 1683879754, "regularMarketDayHigh": 0.1315, "regularMarketDayRange": "0.116 - 0.1315", "regularMarketDayLow": 0.116, "regularMarketVolume": 87924, "regularMarketPreviousClose": 0.132, "fullExchangeName": "Brussels", "regularMarketOpen": 0.1315, "averageDailyVolume3Month": 321633, "averageDailyVolume10Day": 233816, "fiftyTwoWeekLowChange": 0.034900002, "fiftyTwoWeekLowChangePercent": 0.4225182, "fiftyTwoWeekRange": "0.0826 - 0.35", "fiftyTwoWeekHighChange": -0.23249999, "fiftyTwoWeekHighChangePercent": -0.66428566, "fiftyTwoWeekLow": 0.0826, "fiftyTwoWeekHigh": 0.35, "twoHundredDayAverageChange": -0.0434025, "twoHundredDayAverageChangePercent": -0.2697441, "marketCap": 14571057, "forwardPE": -1.0681819, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Bone Therapeutics SA", "nameChangeDate": "2023-05-11", "averageAnalystRating": "1.0 - Strong Buy", "firstTradeDateMilliseconds": 1422950400000, "priceHint": 4, "symbol": "BIOS.BR"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building H (box 24)", "address2": "Rue GranbonprE 11", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 493 09 73 66", "website": "https://www.biosenic.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.", "companyOfficers": [{"maxAge": 1, "name": "Fran\u00e7ois  Rieger", "title": "CEO, Pres & Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Carole  Nicco", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. V\u00e9ronique  Pomi-Schneiter", "title": "Deputy CEO & Exec. Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lieven  Huysse M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}